Photo Clinic: A case of pyoderma gangrenosum that failed antibiotics, steroids, other immunosuppressive agents, thalidomide and cyclosporine.
Case Study: A female patient presents with a case of pyoderma gangrenosum that fails multiple standard treatments.
Genetics research shows great promise for personalized treatment in rheumatology — but diagnostic and prognostic gene tests are years away.
Certolizumab pegol reduces the signs and symptoms of rheumatoid arthritis regardless of how much methotrexate is prescribed, study shows.
While there are many studies that examine how well TNFi biologic therapies work in rheumatoid arthritis, few studies have examined when TNFi can be safely stopped, until now.
Belimumab has been a ground-breaking therapy for patients with systemic lupus erythematosus. In this op-ed, Paul Sufka, M.D., reviews recent studies on belimumab which could lead to new uses.
A new report suggests that reducing or stopping glucocorticoid therapy can be achieved safely with intravenous abatacept.
Eric Morand, M.D., Ph.D., Director of Rheumatology at Monash Health in Australia, speaks with Rheumatology Network about his recent article in Nature Reviews Rheumatology.
Researchers have clarified the contribution of IL-12 and IL-23 in immune regulation.
The development pipeline for psoriasis in summary.